BCABBioAtla, Inc.Nov 13, 2025Q3 2025
Read transcript →BioAtla, Inc. (BCAB) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$4.47
-0.94%
Mkt Cap $5.31M
BCABBioAtla, Inc.Nov 13, 2025BCABBioAtla, Inc.Aug 9, 2025Q2 2025
Read transcript →BCABBioAtla, Inc.May 6, 2025Q1 2025
Read transcript →BCABBioAtla, Inc.Mar 27, 2025Q4 2024
Read transcript →BCABBioAtla, Inc.Nov 9, 2024Q3 2024
Read transcript →BCABBioAtla, Inc.Aug 11, 2024Q2 2024
Read transcript →BCABBioAtla, Inc.May 14, 2024Q1 2024
Read transcript →BCABBioAtla, Inc.Mar 26, 2024Q4 2023
Read transcript →BCABBioAtla, Inc.Nov 12, 2023Q3 2023
Read transcript →BCABBioAtla, Inc.Aug 1, 2023Q2 2023
Read transcript →BCABBioAtla, Inc.May 11, 2023Q1 2023
Read transcript →BCABBioAtla, Inc.Mar 23, 2023Q4 2022
Read transcript →BCABBioAtla, Inc.Nov 6, 2022Q3 2022
Read transcript →BCABBioAtla, Inc.Aug 13, 2022Q2 2022
Read transcript →BCABBioAtla, Inc.May 7, 2022Q1 2022
Read transcript →